Catalent, Inc. CTLT | NYSE

$63.48 $0.00 | 0.00%

After Hours
$0 -$63.48 | -100.00%

Company Overview:

Market Cap: $11.52B
PE Ratio: -27.84
52-Week Range: $42.11 - $63.5
Dividend Yield (FWD): 0.00% ($0.00)

10 Year Performance Metrics:

Total Return (with DRIP): 121.73% (8.29% / yr)
Total Return (no DRIP): 121.73% (8.29% / yr)
Share Price: 121.73%
Dividend Increase: nan%
CTLT 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

CTLT Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
CTLT Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Share Price
CTLT Price CAGR:1Y: 51.54%2Y: 19.76%5Y: 3.79%10Y: 8.08%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

CTLT Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - CTLT
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - CTLT
14-Day FREE Trial Get Full Access Now!

CTLT Earnings, Revenue, Cash & Debt, Shares Outstaning:

CTLT - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
CTLT - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CTLT - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
CTLT - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
CTLT - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
CTLT - Cash & Debt
14-Day FREE Trial Get Full Access Now!
CTLT - Revenue
14-Day FREE Trial Get Full Access Now!
CTLT Revenue CAGR:1Y: 4.18%2Y: 0.05%5Y: 9.01%10Y: 9.36%
CTLT - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
CTLT EPS CAGR:1Y: -82.03%2Y: N/A5Y: N/A10Y: 14.71%
CTLT - Net Income
14-Day FREE Trial Get Full Access Now!
CTLT Net Income CAGR:1Y: -81.96%2Y: N/A5Y: N/A10Y: 20.80%
CTLT - EBITDA
14-Day FREE Trial Get Full Access Now!
CTLT EBITDA CAGR:1Y: 216.67%2Y: -40.65%5Y: -8.54%10Y: 35.93%
CTLT - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
CTLT Free Cash Flow CAGR:1Y: 102.60%2Y: 42.01%5Y: 15.81%10Y: 7.48%
CTLT - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
CTLT Free Cash Flow / Share CAGR:1Y: 102.58%2Y: 42.00%5Y: 15.62%10Y: 7.35%
CTLT - Gross Profit
14-Day FREE Trial Get Full Access Now!
CTLT Gross Profit CAGR:1Y: N/A2Y: -16.24%5Y: 0.37%10Y: 3.75%
CTLT - Expenses
14-Day FREE Trial Get Full Access Now!
CTLT Expenses CAGR:1Y: -32.14%2Y: -38.15%5Y: -4.96%10Y: 6.21%
CTLT - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
CTLT Shares Outstanding CAGR:1Y: 0.55%2Y: 0.28%5Y: 4.55%10Y: 5.32%
CTLT - Share Buybacks
14-Day FREE Trial Get Full Access Now!
CTLT Share Buybacks CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
CTLT - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
CTLT Stock-Based Comp CAGR:1Y: -10.53%2Y: -5.41%5Y: 0.48%10Y: 27.48%
CTLT - Dividends
14-Day FREE Trial Get Full Access Now!
CTLT Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
CTLT - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
CTLT Revenue CAGR:1Y: 4.18%2Y: 0.05%5Y: 9.01%10Y: 9.36%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

CTLT - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CTLT Actual Revenue CAGR:1Y: 4.18%2Y: 0.05%5Y: 9.01%10Y: 9.36%
CTLT - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CTLT Actual EPS CAGR:1Y: -82.03%2Y: N/A5Y: N/A10Y: 14.71%
CTLT - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CTLT Actual Net Income CAGR:1Y: -81.96%2Y: N/A5Y: N/A10Y: 20.80%
CTLT - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
CTLT Actual EBITDA CAGR:1Y: 216.67%2Y: -40.65%5Y: -8.54%10Y: 35.93%

Ratios, Profit Margins & Return on Capital:

CTLT - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
CTLT Net Profit Margin CAGR:1Y: -82.68%2Y: N/A5Y: N/A10Y: 10.47%
CTLT - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
CTLT Gross Profit Margin CAGR:1Y: -4.02%2Y: -16.28%5Y: -7.92%10Y: -5.13%
CTLT - Price to Earnings
14-Day FREE Trial Get Full Access Now!
CTLT - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
CTLT - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
CTLT - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

CTLT Dividends Info:

Annual Dividend: $
Forward Yield: 0%
Ex-Dividend Date:
Lifetime Dividens / Share: $0.00

CTLT Dividend History: Dates, Payments & Yield list

Below is a schedule of all CTLT dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for CTLT

Based on past 10-year performance, here are CTLT growth metrics:

Share price CAGR of +8.29%
Dividend CAGR of +0%
Using CTLT CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

CTLT
Current Price$63.48
Start Shares157.53
Start Value$10,000
 
After 10 years:
Final Share Count157.53
Dividends Payment$0.00
Annual Dividends$0
Yield on cost0.00%
Share Price$129.98
Total Dividends$0
Final Value$20,475

Estimated Future Value + Dividends - CTLT

NOTE: Above numbers are our estimate based on CTLT's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Catalent, Inc. (CTLT) had its IPO on 2014-07-31, and is trader on NYSE stock exchange.

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.

CTLT website: https://www.catalent.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial